46 Infrared heating stage for high-temperature research
Linkam Scientific Instruments, a market leader in temperature- and environment-controlled microscopy, has partnered with the University of Huddersfield to develop the IHS1700, a groundbreaking new infrared heating stage. The IHS1700 reflects a major advancement in thermomicroscopy, combining state-of-the-art infrared technology with precise temperature control for rapid heating.
The IHS1700 offers a temperature range from room temperature up to 1700°C and has an impressive maximum heating rate of 2000°C/min. This advanced heating stage has been rigorously tested by researchers at the University of Huddersfield in their work on metallurgy, mineralogy, and energetic materials analysis, with the results set to be highlighted during the TAC 2025 presentation.
Designed specifically for the study of inorganic materials, the IHS1700 is ideal for high-temperature research, providing excellent atmosphere control in a compact volume.
Dr Gage Ashton, Lecturer in Forensic and Analytical Science at the Thermal Methods Research Unit (TMRU), University of Huddersfield, remarked: “Thermomicroscopy is crucial for revealing complex thermal profiles, often complementing techniques like thermogravimetry and differential scanning calorimetry. While much of the existing literature focuses on organic systems, the ability to rapidly heat to high temperatures in controlled conditions opens up new possibilities for studying alloys, ceramics, and minerals.”
Clara Ko, Sales and Marketing Director at Linkam Scientific Instruments, said: “At Linkam, we’re committed to providing high-performance solutions for both academia and industry. The IHS1700 is an excellent example of how we work closely with our partners to develop systems that meet evolving research demands. We’re excited to add this new technology to our growing product portfolio.”
More information online:
ilmt.co/PL/XxqK 64380pr@reply-direct.com New spatial imaging system advances tissue proteomics research
Thermo Fisher Scientific has launched the Invitrogen™ EVOS™ S1000 Spatial Imaging System, designed to help researchers generate high-quality multiplexed images while streamlining sample processing.
The EVOS S1000 overcomes key challenges in fluorescent microscopy by enabling researchers to capture high-resolution images of multiple tissue samples in just hours. Its advanced spectral technology allows simultaneous imaging of up to nine different protein targets, minimising the need for multiple imaging rounds and preserving tissue integrity.
“Understanding tissue structure is essential for advancing treatments for solid tumours and neurodegenerative diseases,” said Trisha Dowling, Vice President and General Manager for flow and imaging technologies at Thermo Fisher Scientific. “The EVOS S1000 provides a detailed view of tissue microenvironments in their native state, helping researchers accelerate their studies and maximise insights from their samples.”
The system’s compatibility with a wide range of reagents and antibodies ensures seamless integration into existing workflows.
“Our lab manages everything from project design to imaging, so delivering high-quality results efficiently is crucial,” said Carolina Oses Sepúlveda, Researcher and Lab Manager for Spatial Proteomics at SciLifeLab Stockholm. “The EVOS S1000 gives us the flexibility to use any antibody or reagent - or even work without antibodies - reducing processing time and expanding our research capabilities.”
Now available in the United States and Europe, the EVOS S1000 Spatial Imaging System provides researchers with powerful tools to explore complex biological systems and advance disease research.
More information online:
ilmt.co/PL/MKBx 64033pr@reply-direct.com
Super-resolution microscope for single-molecule research
ONI has launched the Aplo Scope, a single-molecule super-resolution microscope designed to capture and analyse molecular interactions with unmatched precision. This advanced system enables researchers to explore nanoscale biological structures in real-time, overcoming limitations of traditional imaging techniques.
The Aplo Scope provides a seamless transition from low-power live-cell imaging to high-resolution microscopy at 20 nm resolution, eliminating the need for complex hardware adjustments. Its compact benchtop design integrates cutting-edge imaging technology with automated workflows, allowing scientists to investigate cellular structures in depth and accelerate discoveries in drug delivery, biomarker identification, and antibody therapeutics.
“The future of biology and drug development depends on our ability to visualise molecular interactions with extraordinary clarity,” said Paul Scagnetti, CEO of ONI. “The Aplo Scope delivers the precision and speed required to unlock new insights, pushing the boundaries of what’s possible in medicine.”
Equipped with a custom-engineered laser module offering precise power control (0.01 kW/cm² to 4.0 kW/cm²), the Aplo Scope enables effortless shifts between live-cell imaging and super-resolution at the click of a button. Its advanced filter set and intuitive software simplify complex assays such as multi-colour imaging and time-lapse studies of biological processes.
Researchers worldwide recognise the impact of single-molecule localisation microscopy (SMLM) in understanding disease mechanisms, improving drug discovery, and advancing patient stratification. “This technology has transformed our approach to biomedical research, revealing insights that were previously inaccessible,” said Lorenzo Albertazzi, Associate Professor at TU/e’s Department of Biomedical Engineering.
ONI designed the Aplo Scope as part of the Aplo Platform - an integrated solution combining application-specific kits and cloud-based software. By streamlining workflows and enhancing data analysis, ONI continues its mission to make super-resolution microscopy both powerful and accessible, helping scientists uncover the molecular foundations of health and disease.
More information online:
ilmt.co/PL/6LVY 64102pr@reply-direct.com Advanced infrared imaging microscope for pharma and life science applications
Bruker Corporation has introduced the LUMOS™ II ILIM, a quantum cascade laser (QCL)-based infrared imaging microscope that sets new benchmarks in speed and resolution. Designed to meet the needs of pharmaceutical and life science researchers, the LUMOS II ILIM enables ultrafast infrared imaging of large sample areas with exceptional spatial detail.
The microscope incorporates a patented coherence reduction technology that minimises artifacts in both transmission and reflection modes, delivering artifact-free infrared laser imaging. With a large field of view and full automation, it facilitates rapid analysis of complex biological tissues.
Dr Guillaume Mabilleau, Clinical Bone Pathologist at Centre Hospitalier Universitaire Angers, France, commented: “The speed and quality of infrared imaging provided by this microscope are remarkable. Its ease of use and high throughput, powered by QCL technology, mark a significant advancement in clinical research. We are excited about the potential applications in improving the diagnosis and treatment of bone diseases.”
The LUMOS II ILIM leverages AI-driven data evaluation to advance research in pharmaceuticals, life sciences, and disease studies. Its integration with Bruker’s MALDI Imaging technology enables multimodal tissue characterisation with deeper analytical insights. Additionally, the system is well-suited for pharmaceutical tablet inspection and particle identification, offering automated sampling capabilities.
For added flexibility, the LUMOS II ILIM includes a Python interface, allowing users to customise workflows to meet specific research needs. More information online:
ilmt.co/PL/lKGD
63840pr@reply-direct.com
INTERNATIONAL LABMATE - JULY 2025
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
